Similarly, a reduction of tumor proliferation has been observed treating nasopharyngeal carcinoma (NPC) cells with Tranilast inhibitor, which conveys to the NF-kB pathway [201]. Here, NFKB1 is linked to nasopharyngeal carcinoma.